Blood-borne non-A, non-B hepatitis is a major form of posttransfusion hepatitis which frequently progresses into malignant liver diseases such as cirrhosis and cancer. In the past decade, a great deal of effort has been devoted to identifying the etiologic agent of blood-borne non-A, non-B hepatitis. Based on its physicochemical properties, the agent was suggested to be a virus (2, 3, 23) , but virtually nothing was known about it until a recent breakthrough made by workers at Chiron (5, 10) . They cloned cDNAs corresponding to part of the genome of a virus isolated from a chimpanzee which had been infected with the blood of a patient with posttransfusion non-A, non-B hepatitis and which subsequently developed acute non-A, non-B hepatitis. The C100-3 protein encoded by one of the cDNA clones was found to react specifically with sera from patients with blood-borne non-A, non-B hepatitis (5, 13) . The close association of anti-C100-3 antibodies with chronic posttransfusion non-A, non-B hepatitis was subsequently confirmed in laboratories worldwide (12, 13, 19) . This virus was thus determined to be a causative agent of non-A, non-B hepatitis and named hepatitis C virus (HCV) (13) .
Houghton et al. (10) have suggested that the virus has a positive-stranded RNA genome and is related to flaviviruses. More recently, several research groups have isolated cDNAs (0.3 to 1.9 kb) spanning part of an HCV genome directly from human patients by using probes based on the Chiron sequence and have found that the HCVs isolated were closely related to Chiron's (approximately 92% amino acid homology) (12, 16, 20) . Despite recent dramatic progress, however, the entire structure of HCV has not been described.
In an effort to identify an etiologic agent of posttransfusion non-A, non-B hepatitis, we have recently cloned overlapping cDNAs that span the entire coding region of HCV isolated from the plasma of Japanese carriers. Our HCV has an 85% amino acid homology to Chiron's and 90 to 98% homology to HCVs cloned by others (10, 12, 16, 20 with combined sera from patients clinically diagnosed as having chronic non-A, non-B hepatitis as described before (30) . Plaque hybridization was carried out as described before (1) . Sequence analysis of cloned cDNA. cDNA inserts were subcloned into the EcoRI site of pUC19 and sequenced by the dideoxynucleotide method after making various deletions with exonuclease III and mung bean nuclease (9) . Verification of sequences was done by resequencing both strands.
Southern blot hybridization. Human placental DNA was digested with BamHI, EcoRI, HindlIl, or PstI, and 10 ,ug of each of the digests was electrophoresed on agarose gels. After blotting to nitrocellulose filters, the filters were hybridized with each HCV cDNA insert labeled with 32P. As a positive control to verify the sensitivity of the detection method, 1 to 10 pg of each insert was mixed with the digests and analyzed in parallel.
Nucleotide sequence accession number. The nucleotide sequence data reported here will appear in the GenBank, EMBL, and DDBJ nucleotide sequence data bases under accession number M58335.
RESULTS AND DISCUSSION
Isolation of cDNA clones of the HCV genome. Blood plasma from potential non-A, non-B hepatitis virus carriers was used as the starting material for cDNA cloning. Viruses were sedimented by continuous-flow ultracentrifugation through a 30% (wt/vol) sucrose cushion. RNA was then prepared and converted into double-stranded cDNA by reverse transcription with random hexanucleotides as primers, and the double-stranded cDNA was inserted into the Xgtll phage vector. After screening of 8.5 x 105 plaques, 9 plaques were found to react specifically with combined sera from patients clinically diagnosed as having chronic posttransfusion non-A, non-B hepatitis. The positive clones contained 0.8-to 3.6-kb overlapping cDNA inserts except for clone BK106 ( possibly, the entire genome of the HCV strain. As marked by circles, triangles, and underlines, the 5' and 3' noncoding regions contain several direct and inverted repeats, which might play a role in replication of the genome. At the end of the 3' noncoding region, a stretch of 12 U residues was found. Whether or not this poly(U) stretch is the 3' tail of the genome is unknown.
Deduced amino acid sequence of encoded protein. The RNA genomes of flaviviruses, including Japanese encephalitis virus (JEV), yellow fever virus, and dengue virus, encode one large polyprotein that is subsequently cleaved into three structural proteins, the core (C) protein, the prematrix (pre-M) protein, which is further processed into the matrix (M) protein, the envelope (E) protein, and seven nonstructural proteins, NS1, NS2a, NS2b, NS3, NS4a, NS4b, and NS5. While the structural proteins form the viral particles, the nonstructural proteins are thought to be involved in replication of the viral genome. In fact, NS3 and NS5 are a helicase and an RNA-dependent RNA polymerase, respectively (11, 15, 24) . The viral protein appears to be processed by at least two proteases, one of cellular origin and the other of viral origin, which recognize and cleave the polyprotein at specific sites (8, 22, 28) .
Based on sequence similarities between HCV and flaviviruses, putative cleavage sites of HCV protein were tentatively assigned (Fig. 3 ) and are shown in the amino acid sequence (Fig. 2 ). It should be stressed, however, that we have no information on the processing of the HCV proteins, and these putative cleavage sites were determined solely by computer analysis. Nevertheless, when the hydrophobicity profiles of the encoded proteins were compared based on the provisional cleavage sites, a significant similarity was found between the nonstructural proteins of HCV and JEV ( (10), and C100 is the region which was used to prepare the antigen for the Ortho HCV diagnosis kit. N.A., Nucleic acid; A.A., amino acid; NT, nucleotides.
protein is 198 amino acids long and has a molecular mass of 21,400 daltons, and its hydrophobic C-terminal half may interact with the host membrane. Potential glycosylation sites are indicated by asterisks in Fig. 2 .
The putative NS1 protein consists of 340 amino acids and has a molecular mass of 38,000 daltons. The flavivirus NS1 has been determined to be a soluble complement-fixing antigen sometimes found on the surface of infected cells (29) . Immunization with the NS1 protein effectively protects hosts from flavivirus infection (25, 26) , perhaps by selective complement-induced lysis of infected cells. The NSls of flaviviruses contain two or more potential glycosylation sites. Similarly, the NS1 of HCV has nine potential glycosylation sites, indicated by asterisks in Fig. 2 .
The putative NS2 and NS4 proteins are 277 and 398 amino acids long. NS3 and NS5, which may be a helicase and an RNA-dependent RNA polymerase, respectively, have 609 and 997 amino acids. They are well conserved among flaviviruses and even in some other viruses. The sequence Gly-Asp-Asp (GDD) is found in all RNA-dependent RNA polymerases, including the NS5s of all flaviviruses, poliovirus, and tobacco mosaic virus (11, 15, 24, 27 
ACaUCACCAUCCCCACCACGAcGAUACGACGCCACGUCGA 251
CCUAGGGCGACUCCGcACAAGC 331
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FIG. 2. Nucleotide and deduced amino acid sequences of the HCV genome. The nucleotide sequence was determined from clones BK157, BK146, BK102, BK112, and BK166 as described in the text. Nucleotides are numbered from the 5' end, and amino acids are numbered from the first methionine in the polyprotein. Potential glycosylation sites (Asn-X-Ser/Thr) are indicated by asterisks. The sequence Gly-Asp-Asp found in all the RNA-dependent RNA polymerases of flaviviruses, poliovirus, tobacco mosaic virus, and cowpea mosaic virus (11) 
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is also contained in the putative NS5 of HCV (amino acids 2736 to 2738 in Fig. 2) .
Sequence homology among HCV cDNA clones and other viruses. Since Houghton et al. (10) first reported a partial sequence of HCV cloned from infected chimpanzees, several groups have isolated cDNAs corresponding to various parts of HCV, and significant sequence heterogeneity was apparent among the isolated cDNA clones. Kubo Our clones have 92% identity at both the nucleic acid and amino acid levels to the HCV sequences (0.6, 0.26, and 1.86 kb) independently isolated by others (12, 16, 20) , while they have 77 and 81% nucleic acid and 86 and 82% amino acid identities, to Chiron's HCV (7.3 kb) and Okamoto's HC-J1 (1.86 kb) sequences, respectively (10, 20) (Table 2) . Sequence variations among the different isolates indicate that HCV tends to change its sequence rather than having numerous subtypes. Nevertheless, production of defective viruses appears to be infrequent. Among the 13 overlapping cDNA clones sequenced (Fig. 5) , only BK112 had a onebase deletion in the coding region. 
